Monday, November 26, 2007

Insurance Stops Covering Intravenous Immune Treatment

After three and a half years on intravenous immune globulin, or IVIG, to treat her multiple sclerosis, insurance is no longer paying for Simone Biase's therapy.

"It's costing about $4,000 dollars a month," said the IVIG patient.

She's paying for it herself for now while appealing her insurance company's decision and trying to stretch her monthly treatments. Many insurance companies are clamping down on covering the costly therapy ... with devastating results for patients.

Click here to read or view this complete news story.

1 comment:

Anonymous said...

Keep posting stuff like this i really like it